| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3390654 | Rheumatic Disease Clinics of North America | 2008 | 7 Pages |
Abstract
Although progress has been made in treatment of pulmonary arterial hypertension, serious challenges remain. This article provides an overview of the challenges faced in treatment of PAH caused by scleroderma. It also provides a glimpse into the future, based on recent developments in the field that hold promise for enhancing the treatment of this disease.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Lewis J. MD,